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Abstract
The New Delhi Metallo-b-lactamase (NDM-1) was first reported in 2009 in a Swedish patient. A recent study reported that
Klebsiella pneumonia NDM-1 positive strain or Escherichia coli NDM-1 positive strain was highly resistant to all antibiotics
tested except tigecycline and colistin. These can no longer be relied on to treat infections and therefore, NDM-1 now
becomes potentially a major global health threat. In this study, we performed modeling studies to obtain its 3D structure
and NDM-1/antibiotics complex. It revealed that the hydrolytic mechanisms are highly conserved. In addition, the detailed
analysis indicates that the more flexible and hydrophobic loop1, together with the evolution of more positive-charged
loop2 leads to NDM-1 positive strain more potent and extensive in antibiotics resistance compared with other MBLs.
Furthermore, through biological experiments, we revealed the molecular basis for antibiotics catalysis of NDM-1 on the
enzymatic level. We found that NDM-1 enzyme was highly potent to degrade carbapenem antibiotics, while mostly
susceptible to tigecycline, which had the ability to slow down the hydrolysis velocity of meropenem by NDM-1. Meanwhile,
the mutagenesis experiments, including D124A, C208A, K211A and K211E, which displayed down-regulation on
meropenem catalysis, proved the accuracy of our model. At present, there are no effective antibiotics against NDM-1
positive pathogen. Our study will provide clues to investigate the molecular basis of extended antibiotics resistance of
NDM-1 and then accelerate the search for new antibiotics against NDM-1 positive strain in clinical studies.
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Introduction
The New Delhi Metallo-b-lactamase (NDM-1) was first
reported in 2009 in a Swedish patient, who travelled to New
Delhi and acquired a urinary tract infection caused by Klebsiella
pneumonia [1]. A recent study reported that Klebsiella pneumonia
NDM-1 positive strain or Escherichia coli NDM-1 positive strain was
highly resistant to all antibiotics tested except tigecycline and
colistin [2]. Since August 2010, the spreading and dissemination of
NDM-1 positive strain has occurred, with cases being globally
reported by medias from countries including United States,
Canada, Sweden, United Kingdom, Austria, Belgium, France,
Netherlands, Germany, Africa, Oman, Australia, Japan and
China [3]. Although NDM-1-positive cases are not currently
prevalent in the worldwide, it can spread through renal or bone
marrow transplantation, dialysis, cerebral infarction, chronic
obstructive pulmonary disease, pregnancy, burns, road traffic
accidents, and cosmetic surgery. In addition, NDM-1 positive
strain can destroy carbapenem antibiotics such as meropenem,
imipenem, doripenem and ertapenem by breaking down the
carbapenem groups of antibiotics, which have been serving as the
basis for the treatment of antibiotic-resistant bacterial infections
and now can no longer be relied on for this purpose due to the
emergence of NMD-1 positive strain. Therefore, the spread of the
pathogenic microorganisms carrying NDM-1 gene (also been
called ‘‘super bugs’’) now becomes potentially a major global
health threat.
NDM-1 belongs to the Metallo-b-lactamase (MBL, class B)
family containing Zn
2+ and other divalent cations as cofactors. It
inactivates almost all classes of b-lactams antibiotics including
carbapenems by catalyzing the hydrolytic cleavage of the substrate
amide bond. On the basis of the protein sequence similarities,
three different lineages, named as subclass B1, B2 and B3 have
been characterized. A number of experimental and theoretical
studies have also been devoted to understanding structural and
mechanistic properties of MBLs [4,5,6,7]. However, since this
novel MBL—NDM-1 is likely more potent and extensive than
known MBLs in inactivating b-lactams antibiotics, it is urgent for
PLoS ONE | www.plosone.org 1 August 2011 | Volume 6 | Issue 8 | e23606us to address the ligand binding properties and catalytic
mechanism of NDM-1 in order to light up the road for the
development of novel antibiotics to combat emerging NDM-1
positive pathogen.
To explore the molecular basis for antibiotics hydrolysis by
NDM-1, homology modeling method was performed to obtain the
3D structure. Then molecular docking method was applied to
obtain the binding modes with antibiotics and the comparison of
NDM-1 with other MBLs complexes was also investigated. In
addition, NDM-1 catalyzed hydrolysis of various antibiotics
substrates was monitored by following the absorbance variations
resulting from the opening of the b-lactam ring, which suggested
that NDM-1 displays different resistant abilities to different kinds
of antibiotics. Based on the modeling results, four point mutants,
including D124A, C208A, K211A and K211E, were made and
their enzymatic activities were measured comparing with the wild-
type. The significantly decreased activity of mutants validated the
accuracy of our model. On the other hand, it shed light on the
catalytic mechanism of the novel NDM-1 from the molecular basis
for the first time. Furthermore, enzymatic activities toward
different antibiotics tested in our study would provide clues to
accelerate the new antibiotics design against NDM-1 positive
strain in further studies.
Results and Discussion
Overall structure of NDM-1 from homology modeling
As the multiple sequences alignment shown in Figure 1A,
among VIM-4 (B1 subclass), CphA (B2 subclass) and FEZ-1 (B3
subclasses), NDM-1 is highly homologous to the B1 subclass (VIM-
4, sequence identity is 37%). In addition, sequence alignment
indicates that NDM-1 contains the identical coordinating residues
(His-His-His) in the Zn
2+(I)-binding site and (Asp-Cys-His) in the
Zn
2+(II)-binding site of the B1 subclass, which implies that NDM-1
belongs to the B1 subclass of MBLs. Accordingly, the crystal
structure of VIM-4 (PDB ID: 2WHG) was used as the template in
homology modeling [8]. As shown in Figure 1B, the overall
structure of NDM-1 shares the common characteristic folding of
ab/ba sandwich, which resembles the architectural features in
other B1 subclass. The active site of NDM-1 is highly homologous
to that of VIM-4. In the active site (Figure 2A), Zn
2+(I) is
coordinated with three conserved histidine residues 120, 122 and
189, while Zn
2+(II) is coordinated with the conserved residues
Asp124, Cys208 and His250, which is exactly consistent with the
X-ray crystal structures [9,10]. A water molecule bridging both
zinc ions acts as the nucleophile during the b-lactam hydrolysis.
Two mobile loops in the active site shown in Figure 1B are
crucial for substrate recognition, binding and catalysis in MBLs
[11,12]. In NDM-1, the loop1, also called the flapping loop, is
composed of amino acids LDMPGFGAVA (residues 65–74).
Compared with the loop1 (QSFDGAVYP) in VIM-2 and VIM-4,
the size of the active site cavity is enlarged with less bulky amino
acids, suggesting a broader substrate profile. Besides it is worth
noting that it is more hydrophobic than others [9]. There is only
one benzene ring of Phe70 in the middle of the loop1 of NDM-1,
and the side-chains of Asp66 and Met67 pointed to the solvent, the
less bulky amino acids, especially for the glycines, are proposed to
make the loop1 more flexible for substrate binding. In the crystal
structure of NDM-1 in complex with hydrolyzed ampicillin (PDB
ID: 3Q6X) [9], the loop1 represents a more open state compared
with our model, while in the crystal structure of apo NDM-1 (PDB
ID: 3S0Z) [10], the loop1 displays a semi-closed state. Conse-
quently, it is proposed to undergo significant conformational
changes during the substrate binding, in different states with or
without substrate. Regarding the loop2, Arg185 and Asn190 in
VIM-2 was proved to play important roles for substrate binding,
catalysis and inhibition through H-bond interactions [12,13].
While in NDM-1, the arginine is mutated to Ala215, which also
enlarges the size of active site cavity. Moreover, Lys211 instead of
Tyr181 in VIM-2, probably plays the similar role of Arg185 in
VIM-2 by forming electrostatic interaction with the carboxyl of
substrate. The detailed comparison of the two loops in NDM-1
and VIM-2 is shown in Figure 2B. Furthermore, two residues,
Lys125 and Tyr229, were pointed to play crucial roles in
stabilizing the conformation of the active site, through H-bond
network (with residues Asn76, Asp90, Thr91, His122 and Ser249)
and hydrophobic interactions (with residues Leu209, Leu218,
Leu221 and Leu269) [9]. Besides the unique residues in the two
loops, the N terminus of NDM-1 is longer than other analogues.
Even without modeled in our structure, it is speculated to assist in
loop1 packing so as to affect the hydrolytic catalysis. NDM-1 also
contains an additional insert between residues 162 and 166, which
is not present in other MBLs. Since the insert is in the opposite side
of the active site, with a distance of around 20 A ˚, its role in the
hydrolysis reaction is still unknown. In summary, the unique
structural characteristics probably contributes to the more potent
hydrolysis and broader substrate range of the novel MBL—NDM-
1, especially for those bulkier antibiotics, which are not degraded
by other MBLs.
Binding modes of antibiotics with NDM-1 suggesting the
conserved hydrolysis mechanism
After the 3D structure of NDM-1 was modeled, molecular
docking study was performed. Two reported effective antibiotics
(tigecycline and colistin) against NDM-1 positive strains [2] and
other 13 well-known antibiotics including carbapenem, which
were reported to be destroyed by NDM-1 positive pathogen, were
docked into the active site of NDM-1. The molecular docking data
indicates that the latter 13 antibiotics fit the active site of NDM-1
quite well. Taking two typical antibiotics, imipenem and
carbapenem as example, the docked complex structures revealed
that although the antibiotics adopted diverse conformations in the
active site, the lactam motifs were positioned in the same
orientation by coordinating with zinc ions tightly (Figure 2C),
which suggested that the catalytic mechanisms were highly
conserved among B1 subclass enzymes, as shown in Figure 3.
Substrate-binding polarizes the lactam bond due to coordination
of the carbonyl oxygen with Zn
2+(I) and the lactam nitrogen with
Zn
2+(II). Attack of the water oxygen leads to oxyanion stabilized
by Zn
2+(I), which is followed by subsequent cleavage of the C-N
bond. Then, the lactam nitrogen is expelled as an anion and
stabilized by coordination with Zn
2+(II) acting as a general acid.
The last step is the protonation of the nitrogen, which is
considered as the rate-limiting and the most controversial step to
date [4]. Compare to other known B1 subclass enzymes such as
VIM-2 and VIM-4, the loop2 of NDM-1 harbors a lysine-rich
positive-charged region, which is more favorable for protonation,
probably accounting for its potent catalytic activity at least in part.
Notably, colistin, the reported antibiotic susceptible for NDM-1
positive pathogens, was not able to fit the active site well probably
due to its bulky volume.
Comparison the complex structure of NDM-1/
meropenem with VIM-2/meropenem and FEZ-1/
meropenem
To gain the structural insight into the mechanism of the potent
hydrolysis of NDM-1, the intermolecular interactions of three
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meropenem were compared and analyzed in details (Figure 4A–
C). In NDM-1 complex structure, the lactam oxygen and the
carboxyl oxygen atoms coordinate with Zn
2+(I) and Zn
2+(II) with
distances of 3.56 A ˚ and 2.64 A ˚ respectively. In addition, the H-
bond between the atom N
D2 of Asn220 and the lactam oxygen
atom with distance of 2.96 A ˚ also contributes to the polarization of
the lactam bond. Meanwhile, the water molecule, which bridges
with the two zinc ions with distances of 1.88 A ˚ and 2.40 A ˚
respectively, can serve as the nucleophile to attack the atom C of
Figure 1. Overall structure of NDM-1 and its sequence alignment with its homologue proteins. A. Sequence alignment of NDM-1 with
VIM-4, FEZ-1 and CphA. The second structure assignment of VIM-4 is labeled on the top of the sequences. Black quadrangles indicate residues that
coordinate with Zn
2+(I), while black circles indicate residues that coordinate with Zn
2+(II). The residues composing of the loop1 of NDM-1 is labeled in
green box. B. Cartoon representation of the overall structure of NDM-1 is in light orange color. The loop1, loop2 and the insertion are colored in red,
the conserve residues coordinating with zinc ions are represented as sticks in gray color, and the zinc ions shown as spheres.
doi:10.1371/journal.pone.0023606.g001
Figure 2. Molecular models of NDM-1 and its complex with antibiotics. A. The active site of NDM-1 with two zinc ions and the coordinating
residues. B. The comparison of the two loops in NDM-1 and VIM-2. The loops and key residues in NDM-1 are colored in gray, while in VIM-2 colored in
green. C. The binding modes of antibiotics imipenem and carbapenem in the active site of NDM-1. The two antibiotics are colored in orange and
yellow sticks respectively, while the key residues in gray sticks. The lactam motifs are all colored in green.
doi:10.1371/journal.pone.0023606.g002
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with the atom N
e2 of Gln123. Together with the fact that the
relatively bulky active site cavity caused by the residue variations
in the flexible loop1, NDM-1 is potent to hydrolyze bulkier
antibiotics. Different with NDM-1/meropenem, the VIM-2/
meropenem has a strong H-bond between the carboxyl of
meropenem and Arg185 in the loop2. Moreover, Phe61 and
Try67 in the loop1 form hydrophobic interactions with merope-
nem, and dramatically reduce the size of the active site cavity.
Structurally, the hydrophobic interactions make the lactam ring
rotate to the loop1 and elongate the distance between the lactam
oxygen and Zn
2+(I) to 4.3 A ˚. (Figure 4B) Consequently, the
shallow active site makes the lactam more difficult to be positioned
in a proper orientation for catalysis, which probably explains its
weaker activity to catalyze antibiotics compared with NDM-1. In
contrast, FEZ-1 shares little structural similarity with NDM-1 and
VIM-2, especially for that the flapping loop is not conserved in
FEZ-1, which leads to a flat active site cleft [14]. Obviously,mer-
openem mediates no other interactions with FEZ-1 except for the
lactam motif (Figure 4C), suggesting the low binding affinity for
substrates. And the FEZ-1/meropenem flexible characteristic
makes the antibiotic little access to proper orientation for
hydrolysis. In agreement with our intermolecular interaction
models of enzymes with antibiotics, the reported minimal
inhibitory concentrations of meropenem for VIM-2 and FEZ-1
positive E.coli strains are both 0.25 mg/ml, while for NDM-1
positive E.coli strain, it is 32 mg/ml [2,15], suggesting that NDM-1
is probably more potent in antibiotics hydrolysis. Besides, the
binding modes of hydrolyzed antibiotics were also investigated.
Taking the hydrolyzed meropenem for example (Figure 5), it is
noticed that the original carboxyl formed electrostatic interactions
with Lys211. The hydrophobic residues such as Leu65, Val73 and
Ala74 in the loop1 formed stable hydrophobic interactions with
the dimethylamino group. It appears that the conformations of
antibiotics undergo slight exchange during the catalysis.
NDM-1 enzymatic activity test prove its potency in the
hydrolysis of carbapenem antibiotics
To validate the results extracted from the in silico study, we went
ahead to perform ‘‘wet’’ experiments to further explore the
detailed molecular basis for the catalytic mechanism of NDM-1.
Firstly, we constructed a 66His and sumo (small ubiquitin-related
modifier) tagged NDM-1 expression plasmid and overexpressed
sumo-NDM-1 in E.coli BL21(DE3) strain; then we purified fusion
protein by Ni-column affinity chromatography, the NDM-1
protein was released from fusion protein by ULP-1 (Ubiquitin-
Like protein-specific Protease 1) protease cleavage. More than
95% pure NDM-1 protein was obtained by final gel filtration
chromatography (Figure 6A, B and C). Secondly, the NDM-1
catalyzed hydrolysis of various antibiotics substrates was moni-
tored by following the absorbance variations resulting from the
opening of the b-lactam ring. The susceptibilities of seven typical
antibiotics were assessed. The chemical structures of these
antibiotics are displayed in Figure 7. As shown in Figure 8A,
NDM-1 rapidly hydrolyzes the carbapenem antibiotics including
meropenem and imipenem, and it harbored moderate catalytic
hydrolysis ability against cephalosporin antibiotics, including
ceftazidime, cefotaxime and cefpirome. In contrast, NDM-1 is
susceptible to tigecycline and monobactam—aztreonam, which is
similar with the catalytic ability of VIM-4 and NDM-1-positive
Enterobacteriaceae [2,8].
To explore the detailed mechanism for the susceptibility of the
two antibiotics against NDM-1 positive strain, 100 mM merope-
nem was used as NDM-1 substrate, then 50 mM and 150 mM
tigecycline or aztreonam were mixed with the reaction system as
the inhibitors. Surprisingly, tigecycline probably displayed a
certain degree of inhibition against NDM-1. The hydrolysis
velocity of meropenem by NDM-1 is partially slowed down when
different concentrations of tigecycline were added into the reaction
system (Figure 8B). For another NDM-1 positive strain susceptive
antibiotic aztreonam, we didn’t see any inhibitory effects on
NDM-1 favorite substrate (data now shown). In short, our data
revealed the molecular basis of the novel MBL-NDM-1, of which
NDM-1 positive strain possessed potent resistance to carbape-
nems. On the other hand, we identified a weak inhibitor—
tigecycline, which was previously reported to inhibit the growth of
NDM-1 harbored Klebsiella pneumonia [2]. Our work may pave the
road in designing inhibitors and new antibiotics susceptible against
NDM-1.
Site point mutations of NDM-1 proved Zn
2+(II) is essential
for the hydrolytic activity
Meanwhile, based on our 3D model, we designed the following
point mutants, including, D124A, C208A, K211A and K211E.
Then the activity of the mutants for meropenem was measured and
the result is shown in Figure 8C. It is obvious that the mutants
almost completely lose their activity in antibiotics hydrolysis. This
result in turn verified the accuracy of our 3D model in which the
Zn
2+(II) is coordinated with the conserved residues Asp124 and
Cys208, in spite that it is still intriguing whether the effect is
structural or functional. However, the decreased catalytic activity
implied the mechanism should be Zn
2+(II) assisted, supporting the
proposal that Zn
2+(II) ion is crucial for stabilizing the development
of a negative charge on the b-lactam nitrogen atom(as show in
Figure 3). Regarding K211A and K211E mutants, the significantly
decreased hydrolysis activity indicated that the electrostatic
interaction between the original carboxyl group of hydrolyzed
antibiotics and positive-charged side-chain of K211 probably afford
one of the driving force for the catalysis. While with respect to loop1
(LDMPGFGAVA), we did the loop displacement with QSFDGA-
VYP in VIM-2 and VIM-4. Different with the point mutants, the
hydrolytic catalysis didn’t decrease compared with the wild-type,
which means only the loop1 change wouldn’t affect the hydrolytic
catalysis very much. Moreover, it was reported that A121F, Q123D
Figure 3. One proposed bis-zinc-form mechanism for the
hydrolysis of cephalosporin scaffold by B1 subclass enzyme
NDM-1.
doi:10.1371/journal.pone.0023606.g003
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hydrolysis activityofNDM-1,provingthe crucialrolesoftheunique
HA(121)HQ(123)D motif compared with HFHDD motif in other
MBLs [10]. Furthermore, since loop1 and loop2 are critical for
substrate bindingand catalysis, more attentionwould be paid on the
glycines in loop1 and lysines in loop2.
Conclusions and future prospects
Nowadays, the antibiotics resistance in Gram-negative bacteria
has already been a great risk to the public health. The newly
emergent NDM-1, called ‘‘superbug’’, possesses more potent
hydrolysis ability toward almost all antibiotics and hence becomes
a new threat in clinical surgery. This is one typical example of the
Figure 4. Complex models comparison between NDM-1(A), VIM-2(B) and FEZ-1(C). Upper panel shows the structural electrostatic surfaces
(the color blue indicates the positive-charge, while red negative-charged), two zinc ions are shown as gray spheres, and antibiotics meropenem is
represented in green sticks. The detailed interactions between meropenem and three enzymes NDM-1 (gray sticks), VIM-2 (yellow sticks) and FEZ-1
(orange sticks) are shown on the lower panel.
doi:10.1371/journal.pone.0023606.g004
Figure 5. Binding mode of hydrolyzed meropenem with NDM-1. The left displays the structural electrostatic surface and the right is the
detailed binding interactions.
doi:10.1371/journal.pone.0023606.g005
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resistant to new antibiotics. It is made much easier by the existence
of plasmids, which can transmit easily from bacterium to
bacterium. In this study, the structural models of NDM-1/
antibiotics complex were obtained from homology modeling and
molecular docking methods. The detailed analysis indicates that
the loop1 of more flexibility and hydrophobic, together with the
loop2 of more positive-charged, leads to NDM-1 more potent in
antibiotics hydrolysis compared with other MBLs. Meanwhile, the
experiments proved that NDM-1 was highly resistant to
carbapenems and cephalosporins and susceptible to aztreoname
and tigecycline, which was firstly implied to slow down the
hydrolysis velocity of meropenem by NDM-1 in our study.
Moreover, the mutant results displayed the molecular basis for the
catalytic mechanism. At present, there are no effective antibiotics
against NDM-1 positive pathogen. An appreciated strategy is to
identify drug candidates from the existing antibiotics, such as
tigecycline, based on the 3D model of NDM-1 by using structure-
based virtual screening (e.g., molecular docking and ligand-based,
receptor-based and pharmacophore-based drug design) in con-
junction with bioassay. This strategy has been used successfully in
the discovery of the compound cinanserin against SARS (severe
acute respiratory syndrome) [16]. Taken together, our study
provided clues to investigate the molecular basis of extended
antibiotics resistance of NDM-1 and shed light upon the discovery
of new antibiotics against NDM-1 positive strains in clinical
studies.
Materials and Methods
Homology model procedure
The protein sequence of NDM-1 from Enterococcus faecium
(HQ256747) was retrieved from NCBI (http://www.ncbi.nlm.nih.
gov) protein database. BLASTP program was then performed to
search for its homologues from the RCSB Protein Databank [17].
Accordingly, the crystal structure of VIM-4 (PDB ID: 2WHG) was
selected as the template [8], whose sequence identity with NDM-1
is 37%. To analyze the sequence conservation, sequences
alignment of NDM-1, VIM-4, CphA and FEZ-1 was performed
and gaps were inserted into the sequences to find an optimal
alignment as shown in Figure 1. The 3D structure of NDM-1 was
then modeled by using the InsightII software (Accelrys Inc., San
Diego, CA, USA) and optimized by energy minimization using the
Amber force field implemented in the Sybyl software package. It
was minimized gradually (hydrogens, side-chains, all) using the
constraints in heavy or backbone atoms to alleviate any remaining
bad steric contacts. The optimized structure of NDM-1 was then
subjected to evaluation by PROCHECK and Profiles-3D to
examine the stereochemical quality and the structural rationality
[18,19]. After verified the rationality, the 3D structure of NDM-1
was subjected to the subsequent study.
Molecular docking method
Glide calculations were performed with Maestro v7.5(Schro-
dinger, Inc.) [20]. Hydrogen atoms and charges were added
during a brief relaxation performed using the Protein Preparation
module in Maestro with the ‘‘Preparation and refinement’’ option,
and a restrained partial minimization was terminated when the
root-mean-square deviation (rmsd) reached a maximum value of
0.3 A ˚ in order to relieve steric clashes. The grid-enclosing box was
centered on the Zn
2+(I) and defined so as to enclose residues
located within 10 A ˚, and a scaling factor of 1.0 was set to van der
Waals (VDM) radii of those receptor atoms with the partial atomic
charge less than 0.25. In the docking process, extra-precision (XP)
docking was adopted to generate the minimized pose, and the
Glide scoring function (G-Score) was used to select the final 20
poses for each antibiotic. Together with reported study, the
reasonable poses were used for the binding mode analysis.
Antibiotics
All antibiotics used in this study were purchased from J&K
SCIENTIFIC LTD., except for kanamycin purchased from
Sangon biotech(Shanghai) Co., Ltd..
Figure 6. NDM-1 protein expression and purification. A. 66His and sumo (small ubiquitin-related modifier) tagged NDM-1 was overexpressed
in E.coli BL21(DE3) strain, the black arrow indicates the sumo-NDM-1 fusion protein. B. The cleaved NDM-1 protein was purified by S75 gel filtration
chromatography. C. SDS-PAGE gel shows the purity of NDM-1 more than 95%.
doi:10.1371/journal.pone.0023606.g006
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PLoS ONE | www.plosone.org 6 August 2011 | Volume 6 | Issue 8 | e23606Figure 7. The chemical structures of the seven antibiotics tested in the assay of NDM-1 catalytic activity.
doi:10.1371/journal.pone.0023606.g007
Figure 8. Hydrolysis activity of NDM-1 by enzymatic assays. A. Seven antibiotics were hydrolyzed by NDM-1 protein. The enzymatic reactions
were dynamically monitored by the degradation of the antibiotics. C0 is the initial concentration of antibiotics. Error bars, s.d. B. Tigecycline inhibited
the hydrolysis activity of NDM-1 to meropenem weakly. Compare with control (black line), 50 mM (red line) and 150 mM (blue line) tigecycline slowed
down the hydrolysis velocity of meropenem by NDM-1. C0 is the initial concentration of meropenem. Error bars, s.d. C. Compare with the wild type
enzyme (pink line), the point mutants C208A (black line), D124A (red line), K211A (green line) and K211E (blue line) totally disrupt the hydrolytic
activity to meropenem; while mutations of loop1 (dark yellow line) hardly affect the NDM-1 hydrolytic activity. C0 is the initial concentration of
meropenem. Error bars, s.d.
doi:10.1371/journal.pone.0023606.g008
Molecular Basis of NDM-1
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The NDM-1 gene, which was obtained as a 900 bp PCR
product from Huashan hospital. A new PCR product with
restriction sites (NdeI on forward site and XhoI on reverse site)
encoding truncation protein from amino acid Q37 to the last
amino acid (designated as NDM-137–270) of NDM-1 were
constructed into a modified pET28 vector. As a result, NDM-
137–270 were expressed as fusion protein with a N-terminal 66His
– SUMO (small ubiquitin-related modifier) tag.
Mutagenesis
The QuickChange II site-directed mutagenesis kit (Stratagene,
La Jolla, CA) was used to introduce all the mutations, including
D124A,C208A,K211A,K211E, replacing residues of loop1(65–74,
LDMPGFGAVA) with VIM-2 corresponding residues (40–
48,QSFDGAVYP), into the gene of NDM-137–270.
Protein Expression and Purification
The expression vectors were transformed into E.coli strain
BL21(DE3). A 5-ml overnight culture of these transformed
bacteria in Luria-Bertani (LB) medium containing 50 mg/ml
kanamycin was used to inoculate 1 liter of LB medium containing
50 mg/ml kanamycin and 20 mM ZnCl2. Bacteria were cultured at
37uC with shaking, until reach an optical density at 600 nm of 0.6,
then transferred to 16uC, induced by 0.4 mM IPTG overnight.
The bacteria were collected by centrifugation and resuspended
in 20 ml lysis buffer containing 20 mM Tris, pH 8.0, 200 mM
NaCl, 0.1% b-mercaptoethanol per liter culture. The bacteria
were ruptured by sonication, and the bacteria debris was removed
by centrifugation at 18000 rpm for 30 min. The cleared
supernatant was load onto a Ni-column, which pre-equilibrated
by lysis buffer, and washed with lysis buffer supplemented with
10 mM imidazole. Then ULP-1 (Ubiquitin-Like protein-specific
Protease 1) was add into the Ni-column, digest the fusion protein
at 4uC overnight. Collect the flow through, concentrated and load
onto a superdex 75 column, which pre-equilibrated by 20 mM
Tris, pH 8.0, 150 mM NaCl, 5 mM DTT. Fractions containing
NDM-137–270 and corresponding mutation proteins were pooled
and concentrated, then stored at 280uC freezer. Protein purity
was more than 95%, estimated by sodium dodecyl sulfate (SDS)-
polyacrylamide gel electrophoresis. The final proteins concentra-
tion were determined by using the molar extinction coefficient at
280 nm of 27,880 M
21 cm
21.
Enzyme activity assay
The NDM-1 catalyzed substrate hydrolysation reaction were
carried out in UV-StarH 96 well microplates (Greiner Bio-One
Ltd.) at room temperature within reaction buffer 50 mM Hepes,
pH 7.5. The antibiotics hydrolysation were monitored by Tecan
infinite 200 multimode and absorbance microplate readers (Tecan
Group Ltd.) in the peak absorbance of various antibiotics.
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